Genome-wide analysis of DNA methylation and the gene expression change in lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 1, 2012, Pages 20-33

  Kwon, Yong Jae ^a   Lee, Seog Joo ^a   Koh, Jae Soo ^a   Kim, Sung Han ^b   Lee, Hae Won ^a   Kang, Moon Chul ^a   Bae, Jae Bum ^c   Kim, Young Joon ^c   Park, Jong Ho ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Digital Genomics Inc   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

DNA methylation; Lung cancer; Microarray; Pyrosequencing

Indexed keywords

CCDC37 PROTEIN; CDO1 PROTEIN; CYTL1 PROTEIN; LMO3 PROTEIN; PROTEIN; SERPINB5 PROTEIN; SLIT2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; EARLY CANCER; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; UPREGULATION;

EID: 84655166524     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182307f62     Document Type: Article

References (50)

1. Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008;83:584-594. (Pubitemid 351720831)
2. Jones PL, Wolffe AP. Relationships between chromatin organization and DNA methylation in determining gene expression. Semin Cancer Biol 1999;9:339-347. (Pubitemid 29532860)
3. Cameron EE, Bachman KE, Myohanen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-107. (Pubitemid 29036293)
4. Toyota M, Suzuki H, Yamashita T, et al. Cancer epigenomics: implications of DNA methylation in personalized cancer therapy. Cancer Sci 2009;100:787-791.
5. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350-1354.
6. Brell M, Tortosa A, Verger E, et al. Prognostic significance of O6- methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 2005;11:5167-5174. (Pubitemid 41003702)
7. Hegi ME, Diserens AC, Godard S, et al. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004;10:1871-1874. (Pubitemid 38375541)
8. Agrelo R, Cheng WH, Setien F, et al. Epigenetic inactivation of the premature aging werner syndrome gene in human cancer. Proc Natl Acad Sci USA 2006;103:8822-8827. (Pubitemid 43878103)
9. Ruike Y, Imanaka Y, Sato F, et al. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 2010;11:137.
10. Cheung HH, Lee TL, Davis AJ, et al. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br J Cancer 2010;102:419-427.
11. Heller G, Zielinski CC, Zochbauer-Muller S. Lung cancer: from singlegene methylation to methylome profiling. Cancer Metastasis Rev 2010; 29:95-107.
12. Morris MR, Ricketts CJ, Gentle D, et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 2011;30:1390-1401.
13. Andrews J, Kennette W, Pilon J, et al. Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number. PLoS One 2010;5: e8665.
14. Rauch T, Li H, Wu X, et al. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 2006;66:7939-7947. (Pubitemid 44299157)
15. Rauch T, Wang Z, Zhang X, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA 2007;104: 5527-5532. (Pubitemid 47175714)
16. Jiang CL, Jin SG, Pfeifer GP. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex. J Biol Chem 2004;279:52456-52464. (Pubitemid 39656621)
17. Cokus SJ, Feng S, Zhang X, et al. Shotgun bisulphite sequencing of the arabidopsis genome reveals DNA methylation patterning. Nature 2008; 452:215-219. (Pubitemid 351380251)
18. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008;359:1367-1380.
19. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-744. (Pubitemid 37328812)
20. Rauch TA, Wu X, Zhong X, et al. A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci USA 2009;106:671-678.
21. Seng TJ, Currey N, Cooper WA, et al. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. Br J Cancer 2008;99:375-382.
22. Yang WM, Inouye C, Zeng Y, et al. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 1996;93: 12845-12850. (Pubitemid 26382731)
23. Gaston K, Fried M. CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. Nucleic Acids Res 1995;23:901-909.
24. Kauder SE, Bosque A, Lindqvist A, et al. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 2009;5: e1000495.
25. Kim SN, Kim NH, Lee W, et al. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region. Mol Cancer Res 2009;7:735-744.
26. Shogren-Knaak M, Ishii H, Sun JM, et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006;311: 844-847. (Pubitemid 43228847)
27. Vettese-Dadey M, Grant PA, Hebbes TR, et al. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J 1996;15:2508-2518. (Pubitemid 26151190)
28. Jovanovic J, Ronneberg JA, Tost J, et al. The epigenetics of breast cancer. Mol Oncol 2010;4:242-254.
29. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-153. (Pubitemid 38198742)
30. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-138. (Pubitemid 30094712)
31. Brena RM, Morrison C, Liyanarachchi S, et al. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. PLoS Med 2007;4:e108.
32. Shames DS, Girard L, Gao B, et al. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 2006;3:e486.
33. Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006;16:383-393. (Pubitemid 43327509)
34. Weber M, Davies JJ, Wittig D, et al. Chromosome-wide and promoter- specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005;37:853-862. (Pubitemid 41077111)
35. Kwon YJ, Lee SJ, Koh JS, et al. Isolating bronchial epithelial cell preparations from gross lung specimens. In Vitro Cell Dev Biol Anim 2009;45:496-499.
36. Woenckhaus M, Klein-Hitpass L, Grepmeier U, et al. Smoking and cancer-related gene expression in bronchial epithelium and non-smallcell lung cancers. J Pathol 2006;210:192-204. (Pubitemid 44463934)
37. Larsen S, Yokochi T, Isogai E, et al. LMO3 interacts with p53 and inhibits its transcriptional activity. Biochem Biophys Res Commun 2010; 392:252-257.
38. Aoyama M, Ozaki T, Inuzuka H, et al. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res 2005;65:4587-4597. (Pubitemid 40740794)
39. Nam E, Park C. Maspin suppresses survival of lung cancer cells through modulation of akt pathway. Cancer Res Treat 2010;42:42-47.
40. Tellez CS, Shen L, Estecio MR, et al. CpG island methylation profiling in human melanoma cell lines. Melanoma Res 2009;19: 146-155.
41. Lonardo F, Li X, Kaplun A, et al. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Curr Pharm Des 2010;16:1877-1881.
42. Dallol A, Krex D, Hesson L, et al. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 2003;22:4611-4616. (Pubitemid 36920705)
43. Dallol A, Morton D, Maher ER, et al. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003;63:1054-1058. (Pubitemid 36278438)
44. Dallol A, Da Silva NF, Viacava P, et al. SLIT2, a human homologue of the Drosophila Slit2 gene has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 2002;62:5874-5880. (Pubitemid 35204748)
45. Dunwell TL, Dickinson RE, Stankovic T, et al. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics 2009;4:265-269.
46. Jin J, You H, Yu B, et al. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Biochem Biophys Res Commun 2009;379: 86-91.
47. Tseng RC, Lee SH, Hsu HS, et al. SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res 2010;70:543-551.
48. Dammann R, Strunnikova M, Schagdarsurengin U, et al. CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur J Cancer 2005;41:1223-1236. (Pubitemid 40725582)
49. Dietrich D, Krispin M, Dietrich J, et al. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients. BMC Cancer 2010;10:247.
50. Kim JS, Ryoo ZY, Chun JS. Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells. J Biol Chem 2007;282:29359-29367